Akero Therapeutics | 4:持股變動聲明-高管 Young Jonathan
Akero Therapeutics | 4:持股變動聲明-高管 Lamy Patrick
Akero Therapeutics | 4:持股變動聲明-高管 Yale Catriona
Akero Therapeutics | 4:持股變動聲明-高管 White William Richard
Akero Therapeutics | 4:持股變動聲明-高管 Gangloff Scott A.
Akero Therapeutics | 4:持股變動聲明-高管 Rolph Timothy
Akero Therapeutics | 4:持股變動聲明-高管 Cheng Andrew
Akero Therapeutics | 4:持股變動聲明-高管 Rolph Timothy
Akero Therapeutics | 4:持股變動聲明-高管 Young Jonathan
Akero Therapeutics | 4:持股變動聲明-高管 Lamy Patrick
Akero Therapeutics | 4:持股變動聲明-高管 Yale Catriona
Akero Therapeutics | 4:持股變動聲明-高管 White William Richard
Akero Therapeutics | 4:持股變動聲明-高管 Cheng Andrew
Akero Therapeutics | 4:持股變動聲明-高管 Cheng Andrew
Akero Therapeutics | 4:持股變動聲明-高管 Young Jonathan
Akero Therapeutics | 4:持股變動聲明-高管 Yale Catriona
Akero Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Janus Henderson Group plc(10.2%)
Akero Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(5.5%)
Akero Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-RTW Investments, LP(8.5%),Roderick Wong, M.D.(8.5%)
Akero Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Alkeon Capital Management LLC(4.8%),Panayotis D. Sparaggis(4.8%)
暫無數據